Neumonía por Pneumocystis jirovecii asociada a hemorragia alveolar difusa en un paciente con trasplante renal / Pneumocystis jirovecii pneumonia associated with diffuse alveolar hemorrhage in a renal transplant patient. Case report

La neumonía por Pneumocystis jirovecii es una enfermedad fúngica oportunista descrita principalmente en pacientes con VIH, sin embargo, tras la introducción de la TARV, ha incrementado su incidencia en pacientes con inmunosupresión no asociada a VIH, como neoplasias hematológicas y trasplantes de órganos sólidos. Presentamos el caso de un varón de 17 años, receptor de un trasplante renal, con inmunosupresión prolongada con corticoesteroides, con cuadro clínico de tos, disnea y fiebre. La TC mostró micronódulos pulmonares centrolobulillares y vidrio esmerilado. El LBA fue compatible con hemorragia alveolar difusa (HAD), con RPC positiva para P. jirovecii. Se descartaron otras infecciones y enfermedades autoinmunes. Recibió tratamiento con cotrimoxazol con buena evolución clínica y mejoría radiológica. Si bien las causas más frecuentes de HAD son etiologías autoinmunes como enfermedades reumatológicas o vasculitis, es prioritario descartar causas infecciosas, incluyendo P. jirovecii, ya que el tratamiento dirigido puede tener un impacto significativo en la mortalidad en este grupo de pacientes.

Pneumocystis jirovecii pneumonia is an opportunistic fungal infection, described mainly in HIV patients, however, after the introduction of ART, its presentation has increased in patients with non-HIV immunosuppression, such as hematological cancers, solid or hematopoietic stem cell transplantation. We report the case of a 17-year-old male, kidney transplant patient, with prolonged immunosuppression with corticoesteroids, with history of cough, dyspnea, and fever. Chest CT evidences centrilobular pulmonary micronodules with ground glass. BAL was performed compatible with diffuse alveolar hemorrhage, with positive PCR for P. jirovecii. Other infections and autoimmune disease were ruled out. He received treatment with cotrimoxazole with clinical improvement of the patient, and follow up chest CT at the end of treatment showed decrease of pulmonary infiltrates. Although the most frequent causes of DAH are autoimmune etiologies such as rheumatic diseases or vasculitis, it is a priority to rule out infectious causes, including P. jirovecii, since targeted treatment could have a significant impact on mortality outcomes in this group of patients.

Clinical characteristics and CT findings of Pneumocystis Jirovecii pneumonia in 46 cases with hematological diseases / 中华血液学杂志

Objective: To summarize the original CT features of Pneumocystis Jirovecii pneumonia in patients with hematological diseases. Methods: A retrospective analysis was carried out in 46 patients with proven pneumocystis pneumonia (PJP) in the Hospital of Hematology, Chinese Academy of Medical Sciences between January 2014 and December 2021. All patients had multiple chests CT and related laboratory examinations, imaging typing were conducted based on the initial CT presentation, and the distinct imaging types were analyzed against the clinical data. Results: In the analysis, there were 46 patients with proven pathogenesis, 33 males, and 13 females, with a median age of 37.5 (2-65) years. The diagnosis was validated by bronchoalveolar lavage fluid (BALF) hexamine silver staining in 11 patients and clinically diagnosed in 35 cases. Of the 35 clinically diagnosed patients, 16 were diagnosed by alveolar lavage fluid macrogenomic sequencing (BALF-mNGS) and 19 by peripheral blood macrogenomic sequencing (PB-mNGS) . The initial chest CT presentation was categorized into 4 types, including ground glass (GGO) type in 25 cases (56.5%) , nodular type in 10 cases (21.7%) , fibrosis type in 4 cases (8.7%) , and mixed type in 5 cases (13.0%) . There was no substantial discrepancy in CT types among confirmed patients, BALF-mNGS diagnosed patients and PB-mNGS diagnosed patients (χ(2)=11.039, P=0.087) . The CT manifestations of confirmed patients and PB-mNGS diagnosed patients were primarily GGO type (67.6%, 73.7%) , while that of BALF-mNGS diagnosed patients were nodular type (37.5%) . Of the 46 patients, 63.0% (29/46) had lymphocytopenia in the peripheral blood, 25.6% (10/39) with positive serum G test, and 77.1% (27/35) with elevated serum lactate dehydrogenase (LDH) . There were no great discrepancies in the rates of lymphopenia in peripheral blood, positive G-test, and increased LDH among different CT types (all P>0.05) . Conclusion: The initial chest CT findings of PJP in patients with hematological diseases were relatively prevalent with multiple GGO in both lungs. Nodular and fibrosis types were also the initial imaging findings for PJP.

Hallazgos radiológicos de la neumonía por Pneumocystis jirovecii en fallecidos cubanos con VIH/sida / Radiological findings of Pneumocystis jirovecii pneumonia in Cuban deceased HIV / AIDS patients

Introducción: La neumonía por Pneumocystis jirovecii (PcP) es una de las enfermedades más frecuentes en los pacientes con VIH/sida y provoca una alta morbilidad y mortalidad. La radiología juega un papel fundamental para su diagnóstico presuntivo. Objetivo: Describir los hallazgos radiológicos de neumonía por Pneumocystis jirovecii en una serie de casos de fallecidos cubanos por VIH/sida, y relacionarlos con el estado inmunológico de los pacientes. Métodos: Se realizó el estudio de una serie de 69 fallecidos por sida con PcP en el Instituto de Medicina Tropical Pedro Kourí desde enero de 1996 a enero de 2014. El diagnóstico de la PcP se confirmó por estudios anatomopatológicos mediante la observación de estructuras compatibles con el hongo. Resultados: De los 69 casos del estudio, 57 (82,6 por ciento) presentaron alteraciones en la radiografía de tórax. De ellos, 44 (77,2 por ciento) y 13 (22,8 por ciento) presentaron un patrón radiológico típico y atípico de la PcP, respectivamente. En 12 (17,4 por ciento) fallecidos la radiografía de tórax fue normal. En 76,8 por ciento de los casos se detectó niveles de linfocitos T CD4+ inferior a 200 cél/ 956;L. La relación entre el patrón radiológico y el estado inmunológico de los fallecidos analizados no fue significativa. Conclusiones: Los hallazgos radiológicos descritos en los fallecidos cubanos por sida con PcP son similares a los informados en la literatura internacional. Sin embargo, el diagnóstico de la PcP no debe excluirse en pacientes con radiografías de tórax normales o con patrones atípicos que presenten un cuadro clínico sugestivo de la enfermedad(AU)

Introduction: Pneumocystis jirovecii pneumonia (PcP) is one of the most common diseases among HIV / AIDS patients, causing great morbidity and mortality. Radiology plays a fundamental role in its presumptive diagnosis. Objective: Describe the radiological findings of Pneumocystis jirovecii pneumonia in a series of Cuban deceased HIV / AIDS patients and relate them to the patients' immune status. Methods: A study was conducted of a series of 69 deceased AIDS patients with PcP at Pedro Kourí Tropical Medicine Institute from January 1996 to January 2014. PcP diagnosis was confirmed through anatomopathological studies based on observation of structures compatible with the fungus. Results: Of the 69 study cases, 57 (82.6 percent) presented alterations in their chest radiographs. Of these, 44 (77.2 percent) and 13 (22.8 percent) followed a typical and atypical radiological pattern, respectively. In 12 deceased patients (17.4 percent) chest radiography was normal. In 76.8 percent of the cases, levels of T CD4+ lymphocytes were below 200 cell/ml. The relationship between the radiological pattern and the immune status of the deceased patients analyzed was not significant. Conclusions: The radiological findings described for Cuban deceased AIDS patients with PcP are similar to those reported in the international literature. However, PcP diagnosis should not be excluded in patients with normal chest radiographs or atypical patterns who present a clinical status suggestive of the disease(AU)

Neumonía por Pneumocystis jiroveci post inicio de tratamiento con infliximab en paciente con enfermedad de Crohn / Pneumocystis jiroveci pneumonia following infliximab therapy in patient with Crohn's disease

There are no evidence-based guidelines about prophylaxis against Pneumocystis jiroveci pneumonia in inflammatory bowel disease. We report a case of P. jiroveci pneumonia in patient with Crohn's disease receiving infliximab and methotrexate. This case emphasizes the importance of considering the possibility of this infection in inflammatory bowel disease patients treated on biological therapy.

Pneumocystis jirovecii pneumonia induced by low-dose methotrexate in a patient with chronic urticaria

Abstract Methotrexate has immunosuppressive effects and is administered for refractory chronic urticaria. We present a case of Pneumocystis jirovecii pneumonia in a patient with refractory chronic urticaria managed by low-dose weekly methotrexate treatment (total cumulative dose 195mg). Our study highlights the importance of providing prompt diagnosis and treatment of Pneumocystis jirovecii pneumonia in patients with chronic urticaria under methotrexate therapy.

Imaging lung manifestations of HIV/AIDS

Advances in our understanding of human immunodeficiency virus [HIV] infection have led to improved care and incremental increases in survival. However, the pulmonary manifestations of HIV/acquired immunodeficiency syndrome [AIDS] remain a major cause of morbidity and mortality. Respiratory complaints are not infrequent in patients who are HIV positive. The great majority of lung complications of HIV/AIDS are of infectious etiology but neoplasm, interstitial pneumonias, Kaposi sarcoma and lymphomas add significantly to patient morbidity and mortality. Imaging plays a vital role in the diagnosis and management of lung of complications associated with HIV. Accurate diagnosis is based on an understanding of the pathogenesis of the processes involved and their imaging findings. Imaging also plays an important role in selection of the most appropriate site for tissue sampling, staging of disease and follow-ups. We present images of lung manifestations of HIV/AIDS, describing the salient features and the differential diagnosis